From Lab Bench to Bedside: Advancing Malaria Treatments through Research, Patents, and Clinical Trials

Purpose of Review

Conventional antimalarial therapies often encounter issues of drug resistance, low bioavailability, and systemic toxicity. However, recent advancements in nanotechnology have opened new avenues for revolutionizing malaria treatment through precise drug delivery systems. This review delves into the multifaceted life cycle of the malaria parasite, highlighting its various stages and the intricate interactions between the parasite, mosquito vector, and human host.

Recent Findings

Nanotechnology has proven to be the most suitable approach for delivering antimalarial drugs to the targeted site with enhanced safety and efficacy. The advent of nanotechnology has led to the development of novel drug delivery systems that offer unprecedented control over drug release, distribution, and targeting. Researchers can encapsulate antimalarial agents by harnessing nanoparticles, liposomes, and other nanocarriers, protecting them from degradation and ensuring their targeted delivery to infected cells. These nanoscale systems also enable the exploitation of unique physicochemical properties that enhance drug solubility, circulation time, and cellular uptake.

Summary

The article overviews recent breakthroughs in nanotechnology-based strategies for combating malaria. From passive targeting exploiting the enhanced permeability and retention effect to active targeting using surface-functionalized nanoparticles that recognize specific receptors on infected cells, these innovations are poised to revolutionize malaria treatment. The potential of combining multiple therapeutic agents within a single nanocarrier for synergistic effects is also discussed. The main focus of this review is the different nanotechnologies that are available for the successful administration of antimalarial drugs. Various nanotechnologies can be used: liposomes, dendrimers, solid lipid nanoparticles, self-micro emulsifying drug delivery systems, ethosomes, niosomes, etc. In this review paper, we will detail the study of different nanotechnologies available for administering antimalarial drugs.

Read more here

Kumari, A., Bajwa, N., Tamana et al. From Lab Bench to Bedside: Advancing Malaria Treatments through Research, Patents, and Clinical Trials. Curr Treat Options Infect Dis 17, 4 (2025). https://doi.org/10.1007/s40506-024-00279-w

Read also our overview article on World Malaria Day here: